This benefit is seen in individuals with and without diabetes, particularly those with a history of cardiovascular disease
Splitting into twice-weekly doses (1.2 mg every 3-4 days) is off-label and should only be done under provider guidance
GH ,
Additionally, carnitine deficiency can occur as a secondary effect of undergoing hemodialysis
The Liver: Reversing MASLD/MASH The most revolutionary aspect of Retatrutide is its impact on Metabolically Dysfunctional-Associated Steatotic Liver Disease (MASLD)
Liver-specific benefits of cotadutide have also been reported in T2D patients showing significantly reduced liver fat content by MRI-PDFF (magnetic resonance imaging-proton density fat fraction) as well as significant reductions in circulating collagen fragment, Pro-C3, as a biomarker for liver fibrosis activity and in the FIB4 index, a risk-factor score for fibrosis 11,12,56,57,58,59